IDEXX Laboratories, Inc. (IDXX) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Diagnostics & Research Branche. Der Hauptsitz des Unternehmens ist in Westbrook, ME, United States. Der aktuelle CEO ist Jonathan J. Mazelsky.
IDXX hat IPO-Datum 1991-06-21, 11,000 Vollzeitbeschäftigte, gelistet an der NASDAQ Global Select, eine Marktkapitalisierung von $46.5B.
IDEXX Laboratories, Inc. is a global developer and manufacturer of diagnostic products and services serving the companion animal veterinary, livestock, poultry, dairy, and water testing markets. The company provides point-of-care veterinary diagnostic instruments and assays, reference laboratory services, practice management software, and diagnostic imaging solutions for veterinary professionals. Additionally, IDEXX offers health monitoring and diagnostic products for livestock and dairy operations, water quality testing solutions for microbial contaminants, and laboratory instruments for biomedical research. Founded in 1983 and headquartered in Westbrook, Maine, the company distributes its products through direct sales teams and independent resellers worldwide.
